-It is unknown whether ventricular fibrillation (VF) studied in experimental models represents in vivo human VF. First, we examined closed chest in vivo VF induced at defibrillation threshold testing (DFT) in four patients with ischemic cardiomyopathy pretransplantation. We examined VF in these same four hearts in an ex vivo human Langendorff posttransplantation. VF from DFT was compared with VF from the electrodes from a similar region in the right ventricular endocardium in the Langendorff using two parameters: the scale distribution width (extracted from continuous wavelet transform) and VF mean cycle length (CL). In a second substudy group where multielectrode phase mapping could be performed, we examined early VF intraoperatively (in vivo open chest condition) in three patients with left ventricular cardiomyopathy. We investigated early VF in the hearts of three patients in an ex vivo Langendorff and compared findings with intraoperative VF using two metrics: dominant frequency (DF) assessed by the Welch periodogram and the number of phase singularities (lasting Ͼ480 ms). Wavelet analysis (P ϭ 0.9) and VF CL were similar between the Langendorff and the DFT groups (225 Ϯ 13, 218 Ϯ 24 ms; P ϭ 0.9), indicating that wave characteristics and activation rate of VF was comparable between the two models. Intraoperative DF was slower but comparable with the Langendorff DF over the endocardium (4.6 Ϯ 0.1, 5.0 Ϯ 0.4 Hz; P ϭ 0.9) and the epicardium (4.5 Ϯ 0.2, 5.2 Ϯ 0.4 Hz; P ϭ 0.9). Endocardial phase singularity number (9.6 Ϯ 5, 12.1 Ϯ 1; P ϭ 0.6) was lesser in number but comparable between in vivo and ex vivo VF. VF dynamics in the limited experimental human studies approximates human in vivo VF. defibrillation threshold; mapping; intraoperative HUMAN VENTRICULAR FIBRILLATION is cumbersome to study experimentally. It is unknown whether human ventricular fibrillation (VF) studied in the laboratory truly represents in vivo human VF. (15). Although animal models have been used, there exist differences in the spatio-temporal organization of VF, as well as dominant frequency and phase singularity numbers between animal models and humans. Although the Langendorff has been used for various studies on human VF, this model is denervated and unloaded. Few studies have validated the Langendorff model during human VF. Using an active heart transplant, surgical arrhythmia, and implantable cardioverter defibrillator (ICD) implantation program, we studied VF induced in a variety of settings. In pretransplant human hearts in the clinical setting, we examined the dynamics of in vivo closed chest VF induced at defibrillation threshold testing (DFT) and then examined VF in the same patient in an ex vivo posttransplant Langendorff model. Similarly, in a separate group of patients, we studied in vivo open chest pretransplant VF mapped intraoperatively with VF induced in three other hearts posttransplant Langendorff. We tested the hypothesis that the VF dynamics in the human Langendorff was comparable with closed chest and open chest in vivo human VF.
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MATERIALS AND METHODS
Uniquely, we designed two substudies comparing characteristics of VF induced in the clinical setting with that induced in the experimental Langendorff in the same patients. More specifically, VF induced in the experimental Langendorff model was compared with VF characteristics in two in vivo models: a closed chest model (with VF induced during DFT) and an open chest model (with VF induced intraoperatively).
Two separate research protocols were approved by the University Health Network ethics committee-one for the retrospective analysis of old electrograms and one for explanted hearts (REB No. 09-0297-BE and REB No. 05-0638-T). Informed consent was obtained from each patient.
Substudy I Patients (Langendorff vs. In Vivo Closed Chest Model)
We identified four patients (2 male, 2 female; mean age 48 Ϯ 11.8 years) with ischemic cardiomyopathy who had undergone DFT and were later planned for cardiac transplantation. We studied the clinical characteristics of VF at the time of DFT. In the posttransplant setting, we subsequently examined VF characteristics from the explanted hearts of these same patients. The VF characteristics examined are outlined below in Data Analysis. Table 1 shows patient baseline characteristics.
Substudy II Patients (Langendorff vs. In Vivo Open Chest Model)
We conducted a similar study in a separate group of three patients (2 male, 1 female; mean age 47 Ϯ 11 years) with ischemic left ventricular (LV) cardiomyopathy who were undergoing intraoperative ventricular tachycardia (VT) mapping and later had cardiac transplantation. All patients had severe LV dysfunction due to previous anterior infarct. The indication for surgery was either refractory ventricular arrhythmia or uncontrolled heart failure. Simultaneous unipolar and bipolar recordings of LV endocardial and global epicardial activation were obtained. We studied characteristics of VF at the time of intraoperative mapping and compared these with VF characteristics from three other explanted hearts following cardiac transplantation. The VF characteristics examined are outlined below in Data Analysis. Table 2 shows patient baseline characteristics of the three explanted hearts following cardiac transplantation. After the heart had been placed on bypass but before instituting cold cardioplegia, we collected VF episodes that occurred during VT induction. The segments selected for analysis were at least 1 s after the onset of VF.
Human Langendorff Model
The human Langendorff protocol was the same in both substudies. Postexplantation, hearts were placed in cold modified Tyrode's solution [composition (in mmol/l)] of 118.06 NaCl, 4.69 KCl, 3.33 CaCl 2(H2O)2, 1.16 MgSO4, 24.88 NaHCO3, 1.17 NaPO4, and 6.056 glucose and flushed. Explanted hearts had minimal aortic tissue, making retrograde perfusion unfeasible. Consequently, right and left main coronary arteries were selectively perfused. Coronary flow rate was 0.9 -1.1 l/min. Perfusion pressure was 60 -65 mmHg and temperature 37°C. After 10 min stabilization, the protocol was completed within 30 min. Hearts were paced at a cycle length (CL) of 600 ms at twice diastolic threshold from the posterior right ventricular epicardium with hook electrodes. VF for each heart was induced via contact with a 9-volt battery. VF was allowed to persist for 3 min at a time and then terminated using spoon paddles for defibrillation. Three to five episodes of VF were recorded per heart, 3 s after the rhythm had stabilized into an apparently chaotic rhythm with no contraction of the myocardium.
VF criteria were as follows: heart rate Ͼ220 beats/min with irregularly irregular-appearing ECGs on surface electrocardiography. We visually examined the hearts during recordings to aid in differentiating ventricular tachycardia from VF.
Data Collection
For both the Langendorff and open-chest models, a mapping system described elsewhere was used (1, 4) . Briefly, two electrode arrays (112 electrodes each) that can be deployed to simultaneously record endocardial and epicardial electrograms were used. The endocardial electrodes are stitched on the exterior surface of an extensible balloon (Fig. 1A) . Each endocardial electrode consists of two silver beads (2 mm diameter) separated by 2.1 mm center to center. The epicardial sock electrodes are organized in 14 rows of eight electrodes each, mounted on an extensible mesh (4, 20) (Fig. 1B) . Simultaneous unipolar and bipolar electrograms were recorded from all electrodes. Unipolar signals were recorded at 1 ksamples/s (filter: 0.5 Ϫ200 Hz). It was ensured that all 112 electrodes were functional with no broken electrodes.
For ICD data, 6-to 9-s data segments were analyzed. For mapping data, 20-s recordings were made and a 4-s segment was selected for analysis. The recordings were made shortly (1 to 2 s) after confirming presence of VF.
Moreover, two large silver electrodes disposed across the Langendorff bath were used to create a pseudo-ECG signal, recorded by the same system and used as a reference. 
Data Analysis Substudy I (Langendorff vs. in vivo closed chest model).
Only one channel was available from the closed chest model; thus we chose to evaluate differences in the time organization of VF. We therefore compared average rate and time-frequency characteristics of VF measured from both models. For the closed model, average rate was found using the following equation: average rate ϭ 1/DF, where DF is the dominant frequency found at the peak of the periodogram of the intracardiac electrogram using the Welch method. In the Langendorff model, an average DF value from all the electrograms was derived using the same method. Briefly, each signal was detrended (for baseline wander removal) and decimated to 125 Hz. Power spectral density was calculated using Welch's method (averaged modified periodogram) with a 250-sample window, 125-sample overlap, and 500-point fast Fourier transform. The obtained spectral resolution was 0.25 Hz. DF was determined as the frequency corresponding to the peak value of the periodogram between 1.5 and 8 Hz.
Continuous wavelet transform (22) was used for time-frequency analysis Fig. 2 . Morlet wavelet was used in the analysis due to its morphological similarities with the organized segments of VF tracings. The continuous wavelet transform decomposition parameters were analyzed, and the energy distribution over the wavelet scales was computed. A signal is modeled by a combination of different scaled versions of the mother wavelet, and this combination changes depending upon the signal composition. Hence, depending on the signal compositions (or complexity) the distribution of the signal energy over the wavelet scales varies, resulting in a narrower or broader distribution. The width of the scale distribution depends on the complexity of the signal and hence was used as a measure to compare morphological variations in VF electrograms between the two groups. This variation in the distribution width called scale distribution width can then be used to quantify the nature of the VF segment. All signal processing was performed using Matlab 7.5 (Mathworks) with the signal processing toolbox. 
Substudy II (Langendorff vs. in vivo open chest model).
Because spatial information on VF was available from both models, we chose in this substudy to evaluate differences in the spatial organization of VF. In addition to the DF metric described above, we quantified spatial organization by counting the number of phase singularities lasting Ͼ480 ms during VF, using a method described recently (11) .
Statistics
Data were analyzed using SAS 9.1. All variables were expressed as means Ϯ SE. The DF from all the electrodes was averaged in an area to get the mean DF from that area. In substudy I, CL in vivo and ex vivo were compared using Wilcoxon signed rank sum test. In substudy II, DF data were rank transformed and two-way ANOVA was employed on the ranks as a nonparametric measure for comparing dominant frequency between epicardium and endocardium in in vivo and ex vivo models. Number of phase singularities were compared in the endocardium between in vivo and ex vivo models using Wilcoxon Mann Whitney U test. P Ͻ 0.05 was considered significant.
RESULTS

Substudy I
The scale distribution width (wavelet analysis) was not significantly different between the VF induced at DFT and that induced in the same hearts following explants (P ϭ 0.9).
VF mean CL was also similar between the two groups (225 Ϯ 13 ms and 218 Ϯ 24 ms in in vivo and ex vivo models, respectively, ms, P ϭ 0.9) indicating that activation rate of VF was similar between the two models. Table 3 details the dominant frequency and number of phase singularities in the two groups. Intraoperative DF over the endocardium was slower but was not statistically significantly different compared with the Langendorff DF over the endocardium (4.6 Ϯ 0.1, 5.0 Ϯ 0.4 Hz; P ϭ 0.9). Similarly, DF over the epicardium in the intraoperative model was slower but did not reach statistical significance compared with DF over the epicardium in the Langendorff (4.5 Ϯ 0.2, 5.2 Ϯ 0.4 Hz; P ϭ 0.9). Within each group, the difference in DF between epicardium and endocardium was not statistically significant (P ϭ 0.2). Although endocardial phase singularity (9.6 Ϯ 5, 12.1 Ϯ 1; P ϭ 0.6) number was less intraoperatively compared with in the Langendorff, the difference was not statistically significantly different.
Substudy II
DISCUSSION
We validated human VF dynamics in the experimental setting using human hearts before and after explantation. Uniquely, in the same hearts, we examined VF in the clinical setting using ICD tracings, and then in the experimental Langendorff. To evaluate how well ex vivo VF in the Langendorff approximates in vivo VF, we utilized data from two in vivo models. We obtained mapping data from the intraoperative model that lent itself to detailed mapping analysis such as phase singularity assessment. Others have noted the VF mean CL, DF, and the number of phase singularities are robust VF characteristics; thus we utilized these to compare VF between (24) . Differences in the patient population of our study and the aforementioned studies may explain the incongruencies. Zipes et al. (24) studied hearts that were significantly more fibrosed and dilated than those studied by Nanthakumar et al., whose patient population had coronary artery disease. Our study population consisted of patients with ischemic cardiomyopathy having significant fibrosis. The effect of increased fibrosis in facilitating reentry has been noted, and it has been demonstrated that coronary artery disease characteristics alter VF. In one such study the mean CL of VF was prolonged in the presence of myocardial infarction and fibrosis (3, 24) . We found an ex vivo VF CL in the Langendorff of 218 ϩ 24 ms congruent with the in vivo closed chest value noted above. That this similarity exists further supports the value of the Langendorff model in studying human VF. Moreover, the effects on VF CL prolongation caused by extensive fibrosis and ischemic damage are faithfully preserved.
In vivo open chest DF was slower but not different when compared with the Langendorff DF over the endocardium (4.6 Ϯ 0.1, 5.0 Ϯ 0.4 Hz; P ϭ 0.9) and the epicardium (4.5 Ϯ 0.2, 5.2 Ϯ 0.4 Hz; P ϭ 0.9). A comparable value for in vivo open chest VF was found by Nash (5.11 Ϯ 0.25 Hz; P Ͻ 0.0001) (14) .
The observation that both the DF and VF CL were preserved in the ex vivo condition compared with the in vivo model lends validation to the efficacy of the Langendorff model for the study of human VF. As noted previously, no studies have been performed to validate how well ex vivo VF approximates in vivo VF in the human Langendorff. Interestingly, in a porcine model comparing open chest in vivo VF to VF in a Langendorff system, it was shown that heart isolation, followed by electromechanical uncouplers followed by dye had the largest influence on VF dynamics and altered them somewhat (16) . In that study, custom pattern analysis algorithms indicated that VF became slower and more organized and similar to VF in a canine model of heart failure with isolation (8) . It was thought that this was consistent with a decrease in excitability and could be explained by depressed sympathetic activity due to denervation of the heart and perfusion with a solution free of endogenous catecholamines. However, this contrast between in vivo and ex vivo VF episodes was also thought to have been exaggerated because sympathetic tone in vivo was elevated from surgery and early ischemia from loss of coronary perfusion. Although the mother rotor (5) and restitution (6, 17) hypotheses are based entirely on the myogenic nature of fibrillation, recent studies point to a neural basis for VF or neurillation (5) . Some of these studies showed nerve sprouting and sympathetic hyperinnervation in canine models of VF (2) . Left cardiac sympathetic denervation has been shown to raise the threshold for VF, thereby decreasing the probability that a ventricular arrhythmia will degenerate to VF (19) . Although the autonomic nervous system, particularly sympathetic activation, is known to increase the risk of ventricular tachyarrhythmias in sleep studies, and the risk of sudden cardiac death (25) , the mechanism by which this happens is not yet well elucidated (9) . Most studies done on autonomic tone in ventricular tachyarrhythmias are on animal and cellular models. The intrinsic cardiac nervous system is known to have standalone functions, although it is also under central neurogenic control. Parts of the intrinsic cardiac nervous sytem could still be functional in the Langendorff. It is not clear to what extent the Langendorff is fully/partially denervated and what the effects would be. An additional layer of complexity here is what the role of acute denervation would be on cardiac hemodynamics.
The Langendorff model is centrally denervated and not exposed to perfusing catecholamine influences. Our data showed that intraoperative DF was slower but not statistically different compared with the Langendorff DF over the endocardium (4.62 Ϯ 0.69, 5.03 Ϯ 0.82 Hz; P ϭ 0.55) and the epicardium (4.55 Ϯ 0.87, 5.25 Ϯ 0.86 Hz; P ϭ 0.38). More realistic data are likely to be elicited if the perfusate is enhanced. Effect of sympathetics can be reproduced by perfusing catecholamines like epinephrine. Addition of profibrillatory medications to the Langendorff perfusate like the ATP-dependent potassium channel openers pinacidil and levcromakalim that induce shortening of APD and have profibrillatory effects in preclinical studies (21) may also elicit more real life VF data.
In our study, we compared ex vivo human VF with two different in vivo human models and found VF in the Langendorff model to be comparable with VF in the other two models by the metrics defined previously. It was important to validate this human model of VF since animal models may not be truly representative of human VF because of various factors like differences in rotor number and purkinje penetration across different species. This could also be size related because each rotor occupies a minimum area (23) . In small hearts as in the guinea pig and rabbit, a single highly periodic reentrant source has been shown during VF. In the isolated Langendorffperfused guinea pig heart, it has been demonstrated that VF may be the result of a highly periodic reentrant source, which may remain stable for more than 100 rotations (18) . With the assumption that each rotor occupies a minimum area as demonstrated earlier (7), larger hearts as in sheep, dogs, and humans may have more rotors. However, even in the human heart, during early VF, only a few epicardial and endocardial rotors have been demonstrated. The effective heart size (which is a ratio derived from the heart weight and the period of spiral wave rotation) of the human heart is closest to the rabbit heart (15) . Because the effective size takes into account the wavelength of reentry, it has been suggested that VF wave patterns in the human heart would be most similar to those seen in the rabbit heart.
Limitations. Analysis of power is based on effect size estimate and variance, both of which are not available for a novel and rare parametric study such as this one. An important limitation of this study is its small sample size. However, it will be extremely difficult to recruit more patients for a study like this, which involves intraoperative mapping, DFT, and an ex vivo Langendorff setup.
The Langendorff supports unloaded denervated hearts (11, 12) . Unloaded hearts are subject to an altered surrounding pressure compared with the in vivo closed chest condition where the pericardium is intact. In the Langendorff, the mechano-electrical feedback dynamic experienced by the heart is altered compared with the in vivo closed-chest condition. A three-dimensional model recently demonstrated that alterations in the mechano-electric feedback relationship may alter VT morphology and VF presentation (10) . In that study, it was shown that mechano-electical feedback can cause stationary spiral waves to break up, plausibly providing an explanation for the degeneration of VT to VF. The effects of altering the mechano-electrical feedback relationship are not well defined and quantified, however, and further work is required to elucidate the precise nature of these effects.
Conclusion
We examined VF in clinical pretransplant settings and then in the experimental posttransplant Langendorff. Our study suggests that VF dynamics in the human Langendorff model, despite the important limitation of being unloaded and denervated, is comparable with open-chest and closed-chest in vivo VF, lending support for its use in the study of human VF.
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